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Abstract
Recent advances in the field of endodontics have greatly
improved the outcome and success rate of dental
materials. For last three decades, there has been great
interest in the development of bioactive dental material
with the ability to interact and induce surrounding dental
tissues to promote regeneration of pulpal and peri-
radicular tissues. As these bioactive materials are mainly
based on calcium silicates, they are also referred to as
Calcium Silicate materials. The first material introduced
was Mineral Tri-oxide Aggregate, which, due to its
favourable biological properties, gained importance
initially. However, later, due to its drawbacks, like
discolouration, long setting time and difficult
manipulation, several modifications were done and
newer bioactive materials,  such as Biodentine,
BioAggregate, Endosequence, Calcium-Enriched Mixture
etc., were developed. The main applications of these
materials are for pulp capping (direct/indirect),
pulpotomy, perforation repair, resorption defects, ,
apexogenesis and as retrograde filling materials,
apexification and endodontic sealers. This review
discusses the various types of bioactive materials, their
composition, setting mechanism, and literature evidence
for current applications.
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In modern dentistry, the field of endodontics is also
improving with the advent of new materials and
techniques.1 The term bioactivity is defined as materials
that are durable in tissues and have the capability to
undergo interfacial changes with surrounding tissues.
When these bioactive materials contact the tissue fluids,
they release calcium hydroxide (Ca[OH]2), which can
interact with and induce surrounding tissues to promote
their regeneration.2 The major emphasis has been on
the development of bioactive and biocompatible
materials that can specifically promote regeneration of
pulpal and peri-radicular tissues rather than repair.3
Among the bio-materials that have gained great
importance in regenerative endodontics, calcium silicate
(CS)-based materials, like Mineral Tri-oxide Aggregate
(MTA), Biodentine, Bioceramics, calcium-enriched mixture
etc., are common.4 CS-based materials are defined as
those that are composed of either di/tri/tetra- CS phases
with a basic setting mechanism involving hydration
process resulting in the formation of leachate and
crystalline phases.3 CS-based materials were first used
in dentistry in 1878 when Portland cement was used to
fill the root canals. They later became common in practice
and remained so till the 1990s when MTA was first
introduced.5 The main indication of these CS materials
are pulpal and hard tissue regeneration, such as pulp
capping, pulpotomy, apexogenesis, apexification,
endodontic sealers, root perforation repair and as
retrograde filling materials.6 There are certain common
desirable characteristics of CS-based materials (Table 1).
On the basis of chemistry, a classification of CS-based
materials has been mentioned in literature3 (Table 2).
The current narrative review was planned to discuss
bioactive cements, their basic composition, manipulation,
mechanism of setting reaction and clinical applications,
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Table-1: Common properties of Bioactive materials
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drawbacks, and modifications.
Mineral Tri-oxide aggregate (MTA)
In the quest for bioactive and osteo-conductive materials,
the introduction of MTA in 1993 by Dr. Mahmoud
Torabinejad led to a paradigm shift in the application of
dental materials in endodontics.3 Some of the notable
properties of MTA are its good physical properties and
its capability to stimulate hard tissue regeneration as
well as good pulpal response. MTA, when in contact with
dentine of the pulp chamber, stimulates the production
and release of signalling molecules, which are essential
for the formation of new tissue in the pulp space.6 MTA
is also capable of activation of cementoblast and
regeneration of periodontal ligament.7
Composition
The principal constituents of MTA powder are tricalcium
silicate (52-53%), dicalcium silicate (23%), tricalcium
aluminate (0-4%), calcium sulphate (1.5%), and bismuth
oxide (20%) as radio-opacifier.8
Availability
MTA is a fine hydrophilic powder available in single-use
sachets  (1gm) with some manufacturers providing pre-
measured water sachets for the ease of use.9 The first
commercially available product was ProRoot MTA,3 in
the form of grey-coloured powder owing to the presence
of iron (ferrous oxide). As this grey colour affected the
aesthetics, the composition was later modified to replace
ferrous oxide with magnesium oxide and marketed as
white ProRoot MTA in 2002.10
Setting reaction
MTA, being a hydrophilic cement, requires moisture to
set. The presence of moisture during the setting also
improves flexural strength.11  The powder is mixed with
water and a chemical reaction occurs known as hydration.
On hydration, colloidal gel composed of calcium oxide
crystals in an amorphous structure is formed.12-15 The
initial setting time for grey and white MTA is 2.45 hours
and 2.20 hours, respectively. On mixing ,the immediate
value of potential hydrogen (pH) is 10.2 which increases
to 12.5 after 3 hours of mixing. This is comparable to
Ca(OH)2. 16
Manipulation
Manipulation of MTA is difficult owing to its granular
consistency, making it difficult to manage and deliver
at clinical site.17 Specialised carriers such as retro-
amalgam carrier, MTA carrier, Micro-apical placement
system etc. were made available to tackle and enhance
manipulation.3
Modifications of MTA
The main drawbacks of MTA are its long setting time,
discolouration potential, manipulation that makes its
utilisation difficult and sometimes requiring multiple
visits for treatment completion. To minimise these
limitations, and enhance clinical utilisation, the
composition of MTA was modified, and MTA Angelus
was introduced in 2001, in which calcium sulphate was
eliminated from its composition to decrease the setting
time.18 A fast-setting nano-white MTA (NW-MTA) was
also introduced that reduced particle size, resulting in
increased surface area (7.8mg), leading to decrease in
initial setting time from 43 minutes (White MTA) to 6
minutes for NW-MTA. NW-MTA also contains strontium
salts in its composition, improving the bio-activity.17
Addition of sodium hypochlorite (NaOCl) gel has also
been reported to reduce (30-60%) the setting times of
MTA. 17
Light cured based MTA was also introduced to control
Generation Bio-Active materials
Generation I Grey MTA
White MTA
Generation II Modifications to MTA
MTA Angelus
Generation III Endo CPM (Cement Portland Modified)
iRootSP (also retailed as Endosequence BC and SmartPaste Bio)
MTA Obtura,
Tech Biosealer Endo





-Generex A, Generx B
Generation IV Hybrid cements:
- Calcium phosphate/Calcium silicate/Bismutite cement
- NRC (Incorporating HEMA)
- MTA with 4-META/MMA-TBB (4-methacryloxyethyl trimellitate
   anhydride in methyl methacrylate initiated by tri-n-butyl borane)
- Light-cured cements including (TheraCal LC)
MTA: Mineral Tri-oxide Aggregate; HEMA: 2-hydroxyethyl methacrylate
Table-2: Classification of Bioactive materials.
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the sett ing reac tion. Fur ther,  2-hydrox yethyl
m ethacr ylate  (HE MA) and tr iethylene glycol
dimethacrylate (TEGDMA) were added to the liquid
component to initiate the setting reaction.19 Various
other types of MTA, such as Micro-Mega (MM) MTA, and
Ortho MTA, were formulated to improve the limitations
of conventional materials.
Applications and Literature review
Studies have shown good clinical success of MTA when
used as retrograde filling20-21 perforation repair, pulp
capping,2 2, 23 apexification2 4 and pulpotomy.2 5
Formation of natural hard tissue barrier on the surface
of apical plug is important owing to the requirement of
providing biological seal around apical plug. Systematic
reviews and meta-analysis comparing Ca(OH)2 and MTA
in successfully forming hard tissue barrier around open
apices were not significant, but the time needed by MTA
to form apical barrier was significantly lower than
Ca(OH)2.24,26 As a perforation repair material (non-
surgical), systematic reviews and meta-analysis reported
the overall success rate of 81% of MTA.27 Another
systematic review evaluating the revitalisation and apical
placement reported high success rate and successful
outcome.28 When used as root-end filling material after
peri-apical surgery, MTA is considered the gold standard,
with systematic reviews and meta-analyses reporting
significantly better outcome when compared with gutta
percha, glass ionomer cement and amalgam.29 However,
MTA was not significantly different than intermediate
restorative material.29,30 Evidence regarding the use of
MTA as an indirect pulp capping is scarce. A study
compared ProRoot MTA and Dycal as an indirect pulp
capping agent and reported non-significant results at 6
months in terms of calcific bridge thickness.31 As a direct
pulp capping agent, MTA had significantly better
outcome with regard to complete calcific bridge
formation and reducing the inflammation when
compared to Dycal.31-35 A recent systematic review
concluded that the risk of failure was significantly lower
when MTA was used as a direct pulp capping agent in
permanent teeth.36 When considered as pulpotomy
medicament in primary teeth, several systematic reviews
and meta-analyses reported superiority of MTA in
comparison to the other currently used materials, but
they studies failed to find significant difference between
Ca(OH)2 and MTA when used as pulpotomy agent over
cariously exposed pulps.37-41
To further overcome the drawbacks of MTA, newer
bioactive cements have been introduced, with
characteristics similar to MTA but without its
disadvantages.
Biodentine
Biodentine (Septodont) has now been recognised as a
promising material, serving as a chief representative of
the CS family,42 first marketed in 2009. Biodentine has a
wide range of applications, including pulp capping,
pulpotomy medicament, and as an endodontic repair
(perforation repair, resoprtive lesions, root-end filling
material), and can be regarded as a dentine replacement
material. Biodentine, which is technically based on MTA
technology, is formulated to overcome the deficiencies
of MTA.43
Composition
The setting time of the material is 12-13 minutes, which
is significantly less than the MTA.42 This fast-setting
reaction is attributed to the increased particle size,
addition of calcium chloride (CaCl2) in the liquid
component, decreasing the liquid content.43 Studies
have also linked the short setting time to the absence
of di-calcium silicate from the composition of biodentine,
which was associated with a slow hydration reaction.44
Another important difference was the addition of calcium
carbonate which can act as a nucleation site for calcium-
silicate-hydrate (CSH), hence accelerating the setting
reaction.36
Setting reaction
The setting reaction of biodentine is similar to MTA and
results in the formation of CSH and Ca(OH)2. Biodentine
additionally contains calcium carbonate in the powder
which explains the presence of carbonate phase. The tri-
calcium silicate grains in the biodentine are finer than
MTA and the addition of hydrophilic polymer in the
composition makes the manipulation and handling
easier. 44
Applications and literature review
When used as a root-end filling material, biodentine
showed significantly better sealing ability in comparison
to MTA and intermediate restorative material  (IRM).46,47
No significant difference was found when biodentine
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and ProRoot MTA were tested in acidic environment.47
Studies have also reported superior compressive
strength48,49 flexural strength, microhardness, and push-
out bond strength and calcium ion release when
compared to other CS-based cements.50-53 However,
studies have shown conflicting results regarding radio-
opacity of biodentine, and its colour stability.53,54 Direct
contact of biodentine with dentine provided significantly
thicker reparative dentine formation in comparison to
Dycal.55 When biodentine was compared with MTA, no
significant difference was found with regard to calcific
bridge formation after pulp capping.33 Studies comparing
outcomes of biodentine and MTA as pulpotomy agent
in primary teeth also reported insignificant results.56-60
Calcium-enriched mixture cement (CEC)
Calcium-enriched cement (CEC) was introduced in the
field of dentistry in 2006 as an endodontic filling
material.6 1 I t has also got favourable physical
characteristics, like film thickness, flow and setting time.
It also has the capability to set in wet conditions in a
shorter time compared to MTA.61,62 The clinical
applications of CEC are similar to MTA and biodentine,
and it has demonstrated encouraging success when
used as capping, pulpotomy, resorption or repair
material.63-65
Composition
CEC is very similar to MTA.66 In contrast to MTA, CEC has
s im i la r  c o m p o si t i o n  to  de nt i n e  c ont a i n i ng
hydroxyapatite.67
Setting reaction
When CEC powder is mixed with water-based solution,
bioactive calcium and phosphate-enriched materials are
formed as a result of hydration reaction. In addition,
calcium and phosphorous ions are released that are
consumed in the formation of hydroxyapatite.68
CEC appeared to exhibit better physical properties, such
as consistency, manipulation, setting time, antibacterial
and antifungal properties, biocompatibility, lack of
staining and better sealing ability.69
Literature review
A recent review reported that CEC is a suitable alternative
material for vital pulp therapies of primary molars
(mature/immature) with reversible / irreversible pulpitis.69
Asgary et al. reported 5-year success of CEC-pulpotomy
when compared with root canal treatment in mature
permanent teeth with the established diagnosis of
irreversible pulpitis.70 Most of the literature on CEC is
currently based on case reports and case series which
are considered weak levels of evidence. More clinical
trials are needed to be conducted to assess the role of
CEC as a wide-range endodontic application so that
concrete level of evidence is generated.
Bio Aggregate
It is a new tailored adaptaption of MTA now available
for endodontic repair utilising the advanced science of
nanotechnology.
Composition
It is composed of nano-particle-sized tricalcium silicate,
tantalum penta oxide, calcium phosphate and silicon
dioxide, and presents improved performance compared
to MTA.71 Tricalcium silicate is the main component
phase.71 This material is claimed to be an aluminium-
free ceramic biomaterial. Replacing bismuth oxide with
tantlum penta oxide for radio-opacity makes it different
from MTA.71
Setting reaction
The powder has to be mixed with deionized water in a
ratio of 1 g/0.38 mL for 2-5 minutes. The material takes
4 hours to set, and permanent restoration has to be done
after the final set. This turns out to be a clinical
disadvantage if the final restoration has to be placed on
the same day. A nano-composite network of Hydrated
Calcium Silicate (HCS) gel forms a firm tight seal at the
site.71,72
Literature review
It is reported to be biocompatible in human fibroblast
cells and stimulates osteoblastic differentiation in
osteoblasts.73 BioAggregate (Innovative Bioceramix )
stimulates odontoblastic differentiation of human dental
pulp cells.72 Its efficiency in odontoblastic and
mineralisation differentiation is comparable with MTA.
The results are comparable with those observed with
human dental pulp cells (HDPCs) exposed to MTA. Clinical
application of BioAggregate as pulp capping agent
promotes mineralisation of dentine beneath the capping
material, and then stimulates reparative odontogenesis
K. Zafar, S. Jamal, R. Ghafoor
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from the injured dental pulp tissue.72 There
were concerns regarding cytotoxicity of
BioAggregate but Yen et al. found it to be
nontoxic to human cells and it also had the
ability to induce differentiation of  human
periodontal ligament (PDL) fibroblasts.74
Clinical Application
It is similar to MTA with respect to sealing
ability and biocompatibility, but it has more
potential to form hard tissue barrier at the
site. This advantage is due to the presence of
Pi source present in the material. It is indicated
for root perforation repair, root resorption
repair, root-end filling, apexification and pulp
capping.75 Its hard tissue-forming potential
is expected to be greater than MTA because
of the presence of Pi source in Bio-Aggregate,
but the poorer mechanical properties and
long setting time of BioAggregate limits the
situations where it could replace MTA.71
Endosequence
Endosequence BC sealer (Brasseler USA) is another
bioactive material  that is  highly radiopaque,
dimensional ly stable,  hydrophi l ic,  and forms
hydroxyapatite upon setting. It is a material that needs
natural canal moisture in the dentinal tubule for setting
reaction.
Composition
It is a pre-mixed CS in the form of syringe-able paste or
putty with easier handling and more feasible in
application compared to MTA ( Table 3) .61 The
manufacturer claims that the material is aluminium-free,
less soluble, and dimensionally more stable during
setting.76
Setting reaction
It is a radiopaque material with a setting time of 2-4 h.77
Micro hardness reduces in the presence of environmental
moisture whereas premature setting accelerates.78 It
complies with the International Organisation for
Standards (ISO) in terms of dimensional accuracy,
solubility and film thickness. It penetrates dentinal
tubules due to its nano particles. Dentine liquid will
create a mechanical bond with material upon setting.
This results in less shrinkage, thus maintaining
dimensional stability.79 Sealing ability of endosequence
is as good as MTA when used as root-end filling
material.80 In contact with saliva, it forms a hydroxyapatite
layer on the surface.81 Hard tissue is deposited due to
calcium release as it has an alkaline pH. It also has
antibacterial properties against enterococcus faecalis
owing to its high pH.82
Literature Review
An in vitro study has reported that this material up-
regulates alkaline phosphatase (ALP) and denitine
sia loprotein (DSP) genes,  suggesting greater
odontoblastic differentiation potential. In addition, Runx2
determines the lineage of osteoblasts and odontoblasts
from mesenchymal cells, and its expression is high in
response to bioceramics and MTA. 83
Lovato and Sedgley83 investigated the antibacterial
activity of Endosequence against enterococcus (E.)
faecalis and found that Endosequence root repair
material (ERRM) and white ProRoot MTA demonstrated
similar antibacterial efficacy against clinical strains of E.
faecalis. Additionally, another study found that the ERRM
had cell viability similar to MTA.84 These materials are
still evolving and are under research.
Products Composition
ProRoot MTA (Dentsply, Tulsa, OK, USA) Portland cement, bismuth oxide (MSDS)
MTA-angelus (Londrina, PR, Brazil) Tricalcium silicate, dicalcium silicate, tricalcium
aluminate, tetracalcium aluminoferrite, bismuth oxide (MSDS)
MM-MTA (MicroMega, Besançon, France) Mixture of several mineral oxides and bismuth oxides (MSDS)
Ortho MTA (BioMTA, Seoul, Korea) Calcium carbonate, silicon dioxide, aluminum
oxide, dibismuth trioxide (MSDS)
Biodentine (Septodont, Powder: Tricalcium silicate, calcium carbonate and
St. Maur-des-Foss´es, France) oxide, iron oxide, zirconium oxide
Liquid: calcium chloride (accelerator),
hydrosoluble polymer (water reducing agent)
Calcium enriched mixture Calcium oxide, sulphur tri-oxide, P2O5, SiO2. The
other main components are calcium hydroxide,
calcium phosphate, and calcium silicate. Minor
components are Al2O3, Na2O, MgO, Cl.
Bioaggregate (Diadent, Burnaby, Canada) Tricalcium silicate, dicalcium silicate, tantalum
pentoxide, calcium phosphate monobasic,
amorphous silicon oxide (MSDS)
Endosequence  Zirconium oxide, calcium silicates, calcium
phosphate monobasic, calcium hydroxide, filler and
thickening agents.
MTA: Mineral Tri-oxide Aggregate
Table-3: Composition of bioactive cements.
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Clinical Application
It is a suitable material for perforation repair, apical
surgery, apical plug, and pulp capping. It has strengths
and biological properties comparable with MTA .71 It is
easy to handle and apply, and thus can be considered
an alternative to MTA.
Conclusion
MTA has been proven as a table-turner in bio-active
materials and has a wide horizon of applications in
endodontics and restorative dentistry. The newer
modifications and materials are continuously on the
verge of improving the properties by combating the
drawbacks of the previous material. The newer materials
could be seen as the promising alternative to MTA, but
more long-term follow-up studies are needed to this
notion.
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